Digital PCR (dPCR) and Real-time PCR (qPCR) Market by Product (Instruments, Reagents, Software, Services), Application (Clinical, Oncology, Forensics), End-user (Hospitals, Diagnostic Labs, Academia, Pharma-Biotech, CRO) - Global Forecast to 2024

Table of Contents

1.... INTRODUCTION

1.1            OBJECTIVES OF THE STUDY
1.2            MARKET DEFINITION
1.3            STUDY SCOPE
1.3.1             MARKETS COVERED.. 20
1.3.2             YEARS CONSIDERED FOR THE STUDY
1.4            CURRENCY USED FOR THE STUDY
1.5            MARKET STAKEHOLDERS

2.... RESEARCH METHODOLOGY

2.1            RESEARCH DATA
2.1.1             SECONDARY DATA
2.1.1.1           KEY DATA FROM SECONDARY SOURCES
2.1.2             PRIMARY DATA
2.1.2.1           KEY DATA FROM PRIMARY SOURCES
2.1.2.2           BREAKDOWN OF PRIMARIES
2.2            MARKET ESTIMATION METHODOLOGY
2.2.1             REVENUE MAPPING-BASED MARKET ESTIMATION
2.2.2             USAGE-BASED MARKET ESTIMATION
2.2.3             PRIMARY RESEARCH VALIDATION
2.3            DATA TRIANGULATION
2.4            RESEARCH ASSUMPTIONS
2.5            RESEARCH LIMITATIONS

3.... EXECUTIVE SUMMARY

4.... PREMIUM INSIGHTS

4.1            GLOBAL DPCR AND QPCR MARKET OVERVIEW.. 39
4.2            QPCR AND DPCR MARKET, BY REGION, 2019 VS.2024 (USD MILLION)
4.3            GLOBAL QPCR AND DPCR MARKET SHARE, BY PRODUCT AND SERVICE (2019)
4.4            GLOBAL QPCR MARKET, BY APPLICATION, 2019 VS. 2024 (USD MILLION)
4.5            GEOGRAPHICAL SNAPSHOT OF DPCR AND QPCR MARKET

5.... MARKET OVERVIEW

5.1            INTRODUCTION
5.2            MARKET DYNAMICS
5.2.1             KEY MARKET DRIVERS
5.2.1.1           RISING INCIDENCES OF TARGET INFECTIOUS DISEASES AND GENETIC DISORDERS
5.2.1.2           CONTINUOUS TECHNOLOGICAL ADVANCEMENTS IN PCR TECHNOLOGIES
5.2.1.3           INCREASING INVESTMENTS, FUNDS, AND GRANTS
5.2.1.4           INCREASING USE OF BIOMARKER PROFILING FOR DISEASE DIAGNOSTICS
5.2.1.5           SUCCESSFUL COMPLETION OF THE HUMAN GENOME PROJECT
5.2.2             KEY MARKET RESTRAINTS
5.2.2.1           HIGH DEVICE COSTS ASSOCIATED WITH DPCR
5.2.2.2           TECHNICAL LIMITATIONS OF QPCR AND DPCR TECHNIQUES
5.2.3             KEY MARKET OPPORTUNITIES
5.2.3.1           GROWING MARKET PENETRATION IN EMERGING COUNTRIES
5.2.3.2           SHIFT FROM PLANT-DERIVED TO GENOME-BASED DRUG DISCOVERY
5.2.4             KEY MARKET CHALLENGES
5.2.4.1           ADOPTION AND IMPLEMENTATION OF MIQE GUIDELINES
5.2.5             KEY MARKET TRENDS. 51
5.2.5.1           DEVELOPMENT OF COMPACT, PORTABLE, AND LAB-ON-CHIP PCR DEVICES
5.2.5.2           ONGOING TECHNOLOGICAL INTEGRATION WITH THE PCR PROCESS

6.... DPCR AND QPCR MARKET, BY PRODUCT & SERVICE

6.1            INTRODUCTION
6.2            QPCR PRODUCTS & SERVICES
6.2.1             QPCR REAGENTS AND CONSUMABLES
6.2.1.1           GLOBAL QPCR REAGENTS AND CONSUMABLES MARKET, BY APPLICATION
6.2.1.2           GLOBAL QPCR REAGENTS AND CONSUMABLES MARKET, BY END USER
6.2.2             QPCR INSTRUMENTS. 58
6.2.2.1           GLOBAL QPCR INSTRUMENTS MARKET, BY APPLICATION
6.2.2.2           GLOBAL QPCR INSTRUMENTS MARKET, BY END USER
6.2.3             QPCR SOFTWARE AND SERVICES
6.2.3.1           GLOBAL QPCR SOFTWARE AND SERVICES MARKET, BY APPLICATION
6.2.3.2           GLOBAL QPCR SOFTWARE AND SERVICES MARKET, BY END USER
6.3            DPCR PRODUCTS & SERVICES
6.3.1             DPCR INSTRUMENTS. 64
6.3.1.1           GLOBAL DPCR INSTRUMENTS MARKET, BY APPLICATION
6.3.1.2           GLOBAL DPCR INSTRUMENTS MARKET, BY END USER
6.3.2             DPCR REAGENTS AND CONSUMABLES
6.3.2.1           GLOBAL DPCR REAGENTS AND CONSUMABLES MARKET, BY APPLICATION
6.3.2.2           GLOBAL DPCR REAGENTS AND CONSUMABLES MARKET, BY END USER
6.3.3             DPCR SOFTWARE AND SERVICES
6.3.3.1           GLOBAL DPCR SOFTWARE AND SERVICES MARKET, BY APPLICATION
6.3.3.2           GLOBAL DPCR SOFTWARE AND SERVICES MARKET, BY END USER

7.... DPCR AND QPCR MARKET, BY APPLICATION.. 71

7.1            INTRODUCTION
7.2            QPCR APPLICATIONS
7.2.1             CLINICAL APPLICATIONS
7.2.1.1           INFECTIOUS DISEASE TESTING
7.2.1.1.1           THE WIDE AVAILABILITY OF QPCR ASSAYS AND KITS FOR INFECTIOUS DISEASE TESTING IS A KEY FACTOR DRIVING MARKET GROWTH
7.2.1.2           ONCOLOGY TESTING
7.2.1.2.1           ADVENT OF ALTERNATIVE DIAGNOSTIC TECHNOLOGIES FOR ONCOLOGY TESTING TO THE KEY RESTRAINING FACTOR
7.2.1.3           BLOOD SCREENING
7.2.1.3.1           THE ADVANTAGES OFFERED BY QPCR SUCH AS THE ELIMINATION OF POST-AMPLIFICATION PROCESSING AND EASY PROCESS AUTOMATION TO DRIVE THE DEMAND FOR QPCR PRODUCTS
7.2.1.4           TRANSPLANT DIAGNOSTICS
7.2.1.4.1           INCREASING COMMERCIALIZATION OF QPCR PRODUCTS FOR TRANSPLANT DIAGNOSTIC TO DRIVE THE MARKET GROWTH
7.2.1.5           OTHER CLINICAL APPLICATIONS
7.2.2             RESEARCH APPLICATIONS
7.2.2.1           INCREASE IN GENOME-BASED RESEARCH ACTIVITY BOOSTS THE MARKET GROWTH. 79
7.2.3             FORENSIC APPLICATIONS
7.2.3.1           LIMITED ADOPTION OF QPCR IN UNDERDEVELOPED AND DEVELOPING COUNTRIES IS EXPECTED TO RESTRICT THE MARKET GROWTH
7.3            DPCR APPLICATIONS
7.3.1             CLINICAL APPLICATIONS
7.3.1.1           INFECTIOUS DISEASE TESTING
7.3.1.1.1           ACCURACY AND PRECISION OF DPCR HAVE MADE IT A PROMINENT TOOL IN INFECTIOUS DISEASE TESTING
7.3.1.2           ONCOLOGY TESTING
7.3.1.2.1           DPCR PLAYS A VITAL ROLE IN ONCOLOGY TESTING AND CLINICAL STUDIES
7.3.1.3           BLOOD SCREENING
7.3.1.3.1           DPCR OFFERS MULTIPLE ADVANTAGES OVER TRADITIONAL TECHNIQUES FOR BLOOD SCREENING
7.3.1.4           TRANSPLANT DIAGNOSTICS
7.3.1.4.1           LOW MARKET AVAILABILITY OF DPCR PRODUCTS FOR TRANSPLANT DIAGNOSTICS TO REFLECT IN SMALL SHARE OF THIS MARKET SEGMENT
7.3.1.5           OTHER CLINICAL APPLICATIONS
7.3.2             RESEARCH APPLICATIONS
7.3.2.1           WIDE USAGE OF DPCR IN GENETIC RESEARCH IS THE PRIMARY DRIVER FOR MARKET GROWTH
7.3.3             FORENSIC APPLICATIONS
7.3.3.1           THE NEED TO REDUCE THE TIME AND COST OF FORENSIC PROCESSES IS A KEY FACTOR DRIVING MARKET GROWTH

8.... DPCR AND QPCR MARKET, BY END USER

8.1            INTRODUCTION
8.2            QPCR END USERS
8.2.1             HOSPITALS AND DIAGNOSTIC CENTERS
8.2.2             RESEARCH LABORATORIES AND ACADEMIC INSTITUTES
8.2.3             PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
8.2.4             CLINICAL RESEARCH ORGANIZATIONS
8.2.5             FORENSIC LABORATORIES
8.3            DPCR END USERS
8.3.1             HOSPITALS AND DIAGNOSTIC CENTERS
8.3.2             RESEARCH LABORATORIES AND ACADEMIC INSTITUTES
8.3.3             PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
8.3.4             CLINICAL RESEARCH ORGANIZATIONS
8.3.5             FORENSIC LABORATORIES

9.... DPCR AND QPCR MARKET, BY REGION

9.1            INTRODUCTION
9.2            NORTH AMERICA
9.2.1             US
9.2.1.1           US TO DOMINATE THE NORTH AMERICAN DPCR AND QPCR MARKET IN 2019. 112
9.2.2             CANADA
9.2.2.1           GOVERNMENT INITIATIVES FOR SUPPORTING GENOMICS RESEARCH TO DRIVE MARKET GROWTH IN CANADA
9.3            EUROPE
9.3.1             GERMANY
9.3.1.1           GERMANY TO DOMINATE THE EUROPEAN DPCR AND QPCR MARKET
9.3.2             UK
9.3.2.1           GROWING FOCUS ON GENOMICS RESEARCH TO SUPPORT MARKET GROWTH IN THE UK. 120
9.3.3             FRANCE
9.3.3.1           INITIATIVES FOR DEVELOPING GENOMIC MEDICINE TO SUPPORT MARKET GROWTH IN FRANCE
9.3.4             REST OF EUROPE
9.4            ASIA PACIFIC
9.4.1             JAPAN
9.4.1.1           STRONG RESEARCH AND HEALTHCARE INFRASTRUCTURE TO SUPPORT MARKET GROWTH IN JAPAN
9.4.2             CHINA
9.4.2.1           HEALTHCARE INFRASTRUCTURE MODERNIZATION TO SUPPORT MARKET GROWTH IN CHINA

9.4.3             INDIA
9.4.3.1           PRESENCE OF A LARGE TARGET PATIENT POPULATION TO SUPPORT MARKET GROWTH IN INDIA
9.4.4             REST OF APAC
9.5            LATIN AMERICA
9.5.1             BRAZIL
9.5.1.1           BRAZIL DOMINATED THE LATAM MARKET IN 2018
9.5.2             MEXICO
9.5.2.1           FAVORABLE TRADE AGREEMENTS WILL SUPPORT IMPORTS AND IMPROVE THE ACCESSIBILITY TO DPCR AND QPCR INSTRUMENTS IN MEXICO
9.5.3             REST OF LATIN AMERICA
9.6            MIDDLE EAST AND AFRICA
9.6.1             LOW PURCHASING POWER OF END USERS AND INFRASTRUCTURAL LIMITATIONS TO RESTRAIN MARKET GROWTH IN THE MEA

10.. COMPETITIVE LANDSCAPE

10.1          OVERVIEW
10.2          GLOBAL MARKET SHARE ANALYSIS
10.2.1           GLOBAL QPCR MARKET SHARE ANALYSIS (2018)
10.2.2           GLOBAL DPCR MARKET SHARE ANALYSIS (2018)
10.3          COMPETITIVE SCENARIO
10.3.1           KEY PRODUCT LAUNCHES, ENHANCEMENTS, AND APPROVALS (2016–2019)
10.3.2           KEY PARTNERSHIPS AND COLLABORATIONS (2016–2019)
10.3.3           KEY ACQUISITIONS (2016–2019) 149
10.3.4           KEY EXPANSIONS (2016–2019) 150
10.4          COMPETITIVE LEADERSHIP MAPPING
10.4.1           COMPETITIVE LEADERSHIP MAPPING: MAJOR MARKET PLAYERS (2018)
10.4.1.1         VISIONARY LEADERS
10.4.1.2         INNOVATORS
10.4.1.3         DYNAMIC DIFFERENTIATORS
10.4.1.4         EMERGING COMPANIES
10.4.2           COMPETITIVE LEADERSHIP MAPPING: EMERGING COMPANIES/SMES/START-UPS (2018)
10.4.2.1         PROGRESSIVE COMPANIES
10.4.2.2         STARTING BLOCKS
10.4.2.3         RESPONSIVE COMPANIES
10.4.2.4         DYNAMIC COMPANIES

11.. COMPANY PROFILES

11.1          ABBOTT LABORATORIES
11.1.1           BUSINESS OVERVIEW
11.1.2           PRODUCTS OFFERED
11.1.3           RECENT DEVELOPMENTS (2016-2019)
11.2          AGILENT TECHNOLOGIES, INC.
11.2.1           BUSINESS OVERVIEW
11.2.2           PRODUCTS AND SERVICES OFFERED
11.2.3           RECENT DEVELOPMENTS (2016-2019)
11.3          ANALYTIK JENA AG (A WHOLLY OWNED SUBSIDIARY OF ENDRESS+HAUSER AG)
11.3.1           BUSINESS OVERVIEW
11.3.2           PRODUCTS AND SERVICES OFFERED
11.3.3           RECENT DEVELOPMENTS (2016-2019)
11.4          BECTON DICKINSON AND COMPANY
11.4.1           BUSINESS OVERVIEW
11.4.2           PRODUCTS AND SERVICES OFFERED
11.4.3           RECENT DEVELOPMENTS (2016-2019)
11.5          BIOMÉRIEUX S.A.
11.5.1           BUSINESS OVERVIEW
11.5.2           PRODUCTS AND SERVICES OFFERED
11.5.3           RECENT DEVELOPMENTS (2016-2019)
11.6          BIO-RAD LABORATORIES, INC.
11.6.1           BUSINESS OVERVIEW
11.6.2           PRODUCTS AND SERVICES OFFERED
11.6.3           RECENT DEVELOPMENTS (2016-2019)
11.6.4           MNM VIEW
11.7          DANAHER CORPORATION
11.7.1           BUSINESS OVERVIEW
11.7.2           PRODUCTS OFFERED
11.7.3           RECENT DEVELOPMENTS (2016-2019)
11.8          EPPENDORF AG
11.8.1           BUSINESS OVERVIEW
11.8.2           PRODUCTS OFFERED
11.8.3           RECENT DEVELOPMENTS (2016-2019)
11.9          F. HOFFMAN-LA ROCHE LTD.
11.9.1           BUSINESS OVERVIEW
11.9.2           PRODUCTS AND SERVICES OFFERED
11.9.3           RECENT DEVELOPMENTS (2016-2019)

11.10        FLUIDIGM CORPORATION
11.10.1         BUSINESS OVERVIEW
11.10.2         PRODUCTS OFFERED
11.10.3         RECENT DEVELOPMENTS (2016-2019)
11.11        MERCK KGAA
11.11.1         BUSINESS OVERVIEW
11.11.2         PRODUCTS AND SERVICES OFFERED
11.11.3         RECENT DEVELOPMENTS (2016-2019)
11.12        PROMEGA CORPORATION
11.12.1         BUSINESS OVERVIEW
11.12.2         PRODUCTS AND SERVICES OFFERED
11.12.3         RECENT DEVELOPMENTS (2016-2019)
11.13        QIAGEN N.V.
11.13.1         BUSINESS OVERVIEW
11.13.2         PRODUCTS OFFERED
11.13.3         RECENT DEVELOPMENTS (2016-2019)
11.14        TAKARA BIO, INC.
11.14.1         BUSINESS OVERVIEW
11.14.2         PRODUCTS AND SERVICES OFFERED
11.14.3         RECENT DEVELOPMENTS (2016-2019)
11.15        THERMO FISHER SCIENTIFIC, INC.
11.15.1         BUSINESS OVERVIEW
11.15.2         PRODUCTS AND SERVICES OFFERED
11.15.3         RECENT DEVELOPMENTS (2016-2019)
11.15.4         MNM VIEW
12.. APPENDIX

LIST OF TABLES

TABLE 1              GLOBAL DPCR AND QPCR MARKET, BY TECHNOLOGY, 2017–2024 (USD MILLION)
TABLE 2              GLOBAL QPCR PRODUCTS & SERVICES MARKET, BY TYPE,
2017–2024 (USD MILLION)
TABLE 3              QPCR PRODUCTS & SERVICES MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 4              QPCR REAGENTS AND CONSUMABLES MARKET, BY REGION,
2017–2024 (USD MILLION)
TABLE 5              GLOBAL QPCR REAGENTS AND CONSUMABLES MARKET, BY APPLICATION,
2017–2024 (USD MILLION)
TABLE 6              GLOBAL QPCR REAGENTS AND CONSUMABLES MARKET, BY END USER,
2017–2024 (USD MILLION)
TABLE 7              QPCR INSTRUMENTS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 8              GLOBAL QPCR INSTRUMENTS MARKET, BY APPLICATION,
2017–2024 (USD MILLION)
TABLE 9              GLOBAL QPCR INSTRUMENTS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 10            QPCR SOFTWARE AND SERVICES MARKET, BY REGION,
2017–2024 (USD MILLION)
TABLE 11            GLOBAL QPCR SOFTWARE AND SERVICES MARKET, BY APPLICATION,
2017–2024 (USD MILLION)
TABLE 12            GLOBAL QPCR SOFTWARE AND SERVICES MARKET, BY END USER,
2017–2024 (USD MILLION)
TABLE 13            GLOBAL DPCR PRODUCTS & SERVICES MARKET, BY TYPE,
2017–2024 (USD MILLION)
TABLE 14            DPCR PRODUCTS & SERVICES MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 15            DPCR INSTRUMENTS MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 16            GLOBAL DPCR INSTRUMENTS MARKET, BY APPLICATION,
2017–2024 (USD MILLION)
TABLE 17            GLOBAL DPCR INSTRUMENTS MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 18            DPCR REAGENTS AND CONSUMABLES MARKET, BY REGION,
2017–2024 (USD MILLION)
TABLE 19            GLOBAL DPCR REAGENTS AND CONSUMABLES MARKET, BY APPLICATION,
2017–2024 (USD MILLION)
TABLE 20            GLOBAL DPCR REAGENTS AND CONSUMABLES MARKET, BY END USER,
2017–2024 (USD MILLION)
TABLE 21            DPCR SOFTWARE AND SERVICES MARKET, BY REGION,
2017–2024 (USD MILLION)
TABLE 22            GLOBAL DPCR SOFTWARE AND SERVICES MARKET, BY APPLICATION,
2017–2024 (USD MILLION)
TABLE 23            GLOBAL DPCR SOFTWARE AND SERVICES MARKET, BY END USER,
2017–2024 (USD MILLION)
TABLE 24            GLOBAL QPCR MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 25            GLOBAL QPCR CLINICAL APPLICATIONS MARKET, BY TYPE,
2017–2024 (USD MILLION)
TABLE 26            QPCR CLINICAL APPLICATIONS MARKET, BY REGION, 2017–2024 (USD MILLION) 73
TABLE 27            QPCR CLINICAL APPLICATIONS MARKET FOR INFECTIOUS DISEASE TESTING,
BY REGION, 2017–2024 (USD MILLION)
TABLE 28            QPCR CLINICAL APPLICATIONS MARKET FOR ONCOLOGY TESTING, BY REGION, 2017–2024 (USD MILLION)
TABLE 29            QPCR CLINICAL APPLICATIONS MARKET FOR BLOOD SCREENING, BY REGION, 2017–2024 (USD MILLION)
TABLE 30            QPCR CLINICAL APPLICATIONS MARKET FOR TRANSPLANT DIAGNOSTICS,
BY REGION, 2017–2024 (USD MILLION)
TABLE 31            QPCR MARKET FOR OTHER CLINICAL APPLICATIONS, BY REGION,
2017–2024 (USD MILLION)
TABLE 32            QPCR RESEARCH APPLICATIONS MARKET, BY REGION, 2017–2024 (USD MILLION) 79
TABLE 33            QPCR FORENSIC APPLICATIONS MARKET, BY REGION, 2017–2024 (USD MILLION) 80
TABLE 34            GLOBAL DPCR MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 35            GLOBAL DPCR CLINICAL APPLICATIONS MARKET, BY TYPE,
2017–2024 (USD MILLION)
TABLE 36            DPCR CLINICAL APPLICATIONS MARKET, BY REGION, 2017–2024 (USD MILLION) 82
TABLE 37            DPCR CLINICAL APPLICATIONS MARKET FOR INFECTIOUS DISEASE TESTING,
BY REGION, 2017–2024 (USD MILLION)
TABLE 38            DPCR CLINICAL APPLICATIONS MARKET FOR ONCOLOGY TESTING, BY REGION, 2017–2024 (USD MILLION)
TABLE 39            DPCR CLINICAL APPLICATIONS MARKET FOR BLOOD SCREENING, BY REGION, 2017–2024 (USD MILLION)
TABLE 40            DPCR CLINICAL APPLICATIONS MARKET FOR TRANSPLANT DIAGNOSTICS,
BY REGION, 2017–2024 (USD MILLION)
TABLE 41            DPCR MARKET FOR OTHER CLINICAL APPLICATIONS, BY REGION,
2017–2024 (USD MILLION)
TABLE 42            DPCR RESEARCH APPLICATIONS MARKET, BY REGION, 2017–2024 (USD MILLION) 88
TABLE 43            DPCR FORENSIC APPLICATIONS MARKET, BY REGION, 2017–2024 (USD MILLION) 89
TABLE 44            GLOBAL QPCR MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 45            QPCR MARKET FOR HOSPITALS AND DIAGNOSTIC CENTERS, BY REGION,
2017–2024 (USD MILLION)
TABLE 46            QPCR MARKET FOR RESEARCH LABORATORIES AND ACADEMIC INSTITUTES,
BY REGION, 2017–2024 (USD MILLION)
TABLE 47            QPCR MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES,
BY REGION, 2017–2024 (USD MILLION)
TABLE 48            QPCR MARKET FOR CLINICAL RESEARCH ORGANIZATIONS, BY REGION,
2017–2024 (USD MILLION)
TABLE 49            QPCR MARKET FOR FORENSIC LABORATORIES, BY REGION,
2017–2024 (USD MILLION)
TABLE 50            GLOBAL DPCR MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 51            DPCR MARKET FOR HOSPITALS AND DIAGNOSTIC CENTERS, BY REGION,
2017–2024 (USD MILLION)
TABLE 52            DPCR MARKET FOR RESEARCH LABORATORIES AND ACADEMIC INSTITUTES,
BY REGION, 2017–2024 (USD MILLION)
TABLE 53            DPCR MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES,
BY REGION, 2017–2024 (USD MILLION)
TABLE 54            DPCR MARKET FOR CLINICAL RESEARCH ORGANIZATIONS, BY REGION,
2017–2024 (USD MILLION)
TABLE 55            DPCR MARKET FOR FORENSIC LABORATORIES, BY REGION,
2017–2024 (USD MILLION)
TABLE 56            DPCR AND QPCR MARKET, BY REGION, 2017–2024 (USD MILLION)
TABLE 57            NORTH AMERICA: QPCR MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 58            NORTH AMERICA: DPCR MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 59            NORTH AMERICA: QPCR MARKET, BY PRODUCT & SERVICE,
2017–2024 (USD MILLION)
TABLE 60            NORTH AMERICA: DPCR MARKET, BY PRODUCT & SERVICE,
2017–2024 (USD MILLION)
TABLE 61            NORTH AMERICA: QPCR MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 62            NORTH AMERICA: DPCR MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 63            NORTH AMERICA: QPCR MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 64            NORTH AMERICA: DPCR MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 65            US: QPCR MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
TABLE 66            US: DPCR MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
TABLE 67            CANADA: QPCR MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
TABLE 68            CANADA: DPCR MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
TABLE 69            EUROPE: QPCR MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 70            EUROPE: DPCR MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 71            EUROPE: QPCR MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
TABLE 72            EUROPE: DPCR MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
TABLE 73            EUROPE: QPCR MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 74            EUROPE: DPCR MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 75            EUROPE: QPCR MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 76            EUROPE: DPCR MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 77            GERMANY: QPCR MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
TABLE 78            GERMANY: DPCR MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
TABLE 79            UK: QPCR MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
TABLE 80            UK: DPCR MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
TABLE 81            FRANCE: QPCR MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
TABLE 82            FRANCE: DPCR MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
TABLE 83            ROE: QPCR MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
TABLE 84            ROE: DPCR MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
TABLE 85            APAC: QPCR MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 86            APAC: DPCR MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 87            ASIA PACIFIC: QPCR MARKET, BY PRODUCT & SERVICE,
2017–2024 (USD MILLION)
TABLE 88            ASIA PACIFIC: DPCR MARKET, BY PRODUCT & SERVICE,
2017–2024 (USD MILLION)
TABLE 89            ASIA PACIFIC: QPCR MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 90            ASIA PACIFIC: DPCR MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 91            ASIA PACIFIC: QPCR MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 92            ASIA PACIFIC: DPCR MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 93            JAPAN: QPCR MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
TABLE 94            JAPAN: DPCR MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
TABLE 95            CHINA: QPCR MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
TABLE 96            CHINA: DPCR MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
TABLE 97            INDIA: QPCR MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
TABLE 98            INDIA: DPCR MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
TABLE 99            ROAPAC: QPCR MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
TABLE 100          ROAPAC: DPCR MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
TABLE 101          LATIN AMERICA: QPCR MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 102          LATIN AMERICA: DPCR MARKET, BY COUNTRY, 2017–2024 (USD MILLION)
TABLE 103          LATIN AMERICA: QPCR MARKET, BY PRODUCT & SERVICE,
2017–2024 (USD MILLION)
TABLE 104          LATIN AMERICA: DPCR MARKET, BY PRODUCT & SERVICE,
2017–2024 (USD MILLION)
TABLE 105          LATIN AMERICA: QPCR MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 106          LATIN AMERICA: DPCR MARKET, BY APPLICATION, 2017–2024 (USD MILLION)
TABLE 107          LATIN AMERICA: QPCR MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 108          LATIN AMERICA: DPCR MARKET, BY END USER, 2017–2024 (USD MILLION)
TABLE 109          BRAZIL: QPCR MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
TABLE 110          BRAZIL: DPCR MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
TABLE 111          MEXICO: QPCR MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
TABLE 112          MEXICO: DPCR MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
TABLE 113          ROLATAM: QPCR MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
TABLE 114          ROLATAM: DPCR MARKET, BY PRODUCT & SERVICE, 2017–2024 (USD MILLION)
TABLE 115          MIDDLE EAST AND AFRICA: QPCR MARKET, BY PRODUCT & SERVICE,
2017–2024 (USD MILLION)
TABLE 116          MIDDLE EAST AND AFRICA: DPCR MARKET, BY PRODUCT & SERVICE,
2017–2024 (USD MILLION)
TABLE 117          MIDDLE EAST AND AFRICA: QPCR MARKET, BY APPLICATION,
2017–2024 (USD MILLION)
TABLE 118          MIDDLE EAST AND AFRICA: DPCR MARKET, BY APPLICATION,
2017–2024 (USD MILLION)
TABLE 119          MIDDLE EAST AND AFRICA: QPCR MARKET, BY END USER,
2017–2024 (USD MILLION)
TABLE 120          MIDDLE EAST AND AFRICA: DPCR MARKET, BY END USER,
2017–2024 (USD MILLION)

LIST OF FIGURES

FIGURE 1            RESEARCH DESIGN
FIGURE 2            RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
FIGURE 3            MARKET SIZE ESTIMATION METHODOLOGY: GLOBAL DPCR AND QPCR MARKET
FIGURE 4            DATA TRIANGULATION
FIGURE 5            GLOBAL QPCR PRODUCTS & SERVICES MARKET, BY TYPE, 2019 VS. 2024
FIGURE 6            GLOBAL DPCR PRODUCTS & SERVICES MARKET, BY TYPE, 2019 VS. 2024
FIGURE 7            GLOBAL QPCR MARKET, BY APPLICATION, 2019 VS. 2024
FIGURE 8            GLOBAL DPCR MARKET, BY APPLICATION, 2019 VS. 2024
FIGURE 9            APAC IS EXPECTED TO GROW AT THE HIGHEST RATE DURING
THE FORECAST PERIOD
FIGURE 10          RISING INCIDENCES OF TARGET INFECTIOUS DISEASES AND GENETIC DISORDERS IS EXPECTED TO DRIVE MARKET GROWTH
FIGURE 11          NORTH AMERICA IS EXPECTED TO DOMINATE BOTH QPCR AND DPCR MARKETS DURING THE FORECAST PERIOD
FIGURE 12          REAGENTS AND CONSUMABLES TO HOLD THE LARGEST SHARE IN THE GLOBAL DPCR AND QPCR MARKETS IN 2019
FIGURE 13          INFECTIOUS DISEASE TESTING TO BE THE FASTEST GROWING APPLICATION IN QPCR MARKET DURING FORECAST PERIOD
FIGURE 14          ASIA PACIFIC TO WITNESS HIGHEST GROWTH DURING THE FORECAST PERIOD
FIGURE 15          DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 16          GLOBAL BURDEN OF HIV INFECTIONS, BY REGION, 2017
FIGURE 17          GROWING GERIATRIC POPULATION ACROSS KEY GEOGRAPHIES (2017 VS. 2030)
FIGURE 18          TRADITIONAL PCR VS. QPCR AND DPCR: A COMPARATIVE STUDY
FIGURE 19          REAGENTS AND CONSUMABLES SEGMENT TO DOMINATE THE QPCR PRODUCTS & SERVICES MARKET DURING THE FORECAST PERIOD
FIGURE 20          INSTRUMENTS SEGMENT TO WITNESS THE HIGHEST GROWTH IN THE DPCR PRODUCTS & SERVICES MARKET DURING THE FORECAST PERIOD
FIGURE 21          NORTH AMERICA: DPCR AND QPCR MARKET SNAPSHOT
FIGURE 22          EUROPE: DPCR AND QPCR MARKET SNAPSHOT
FIGURE 23          ASIA PACIFIC: DPCR AND QPCR MARKET SNAPSHOT
FIGURE 24          LATIN AMERICA: DPCR AND QPCR MARKET SNAPSHOT
FIGURE 25          KEY DEVELOPMENTS BY LEADING MARKET PLAYERS IN THE DPCR AND
QPCR MARKET, 2016–2019
FIGURE 26          GLOBAL QPCR MARKET SHARE ANALYSIS, BY KEY PLAYER (2018)
FIGURE 27          GLOBAL DPCR MARKET SHARE ANALYSIS, BY KEY PLAYER (2016)
FIGURE 28          GLOBAL COMPETITIVE LEADERSHIP MAPPING (OVERALL MARKET)
FIGURE 29          COMPETITIVE LEADERSHIP MAPPING (SME/START-UPS)
FIGURE 30          ABBOTT LABORATORIES: COMPANY SNAPSHOT (2018)
FIGURE 31          AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2018)
FIGURE 32          ENDRESS+HAUSER AG: COMPANY SNAPSHOT (2017)
FIGURE 33          BECTON DICKINSON AND COMPANY: COMPANY SNAPSHOT (2018)
FIGURE 34          BIOMÉRIEUX S.A.: COMPANY SNAPSHOT (2018)
FIGURE 35          BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2018)
FIGURE 36          DANAHER CORPORATION: COMPANY SNAPSHOT (2018)
FIGURE 37          EPPENDORF AG: COMPANY SNAPSHOT (2017)
FIGURE 38          ROCHE DIAGNOSTIC DIVISION: COMPANY SNAPSHOT (2018)
FIGURE 39          FLUIDIGM CORPORATION: COMPANY SNAPSHOT (2018)
FIGURE 40          MERCK KGAA: COMPANY SNAPSHOT (2018)
FIGURE 41          QIAGEN N.V.: COMPANY SNAPSHOT (2018)
FIGURE 42          TAKARA BIO, INC.: COMPANY SNAPSHOT (2018)
FIGURE 43          THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2018)

当レポートのプレスリリースは発行されておりません。